Traditional Chinese medicines derived natural inhibitors of ferroptosis on ischemic stroke

被引:0
|
作者
Wang, Yongliang [1 ]
Lan, Xiaobing [1 ]
Liu, Ning [1 ,3 ]
Ma, Lin [1 ,2 ]
Du, Juan [1 ]
Wei, Wei [1 ]
Hai, Dongmei [2 ,3 ]
Wu, Jing [2 ,4 ]
Yu, Jianqiang [1 ,2 ,3 ]
Liu, Yue [1 ]
机构
[1] Ningxia Med Univ, Sch Pharm, Yinchuan 750000, Peoples R China
[2] Ningxia Med Univ, Ningxia Key Lab Drug Dev & Gener Drug Res, Yinchuan 750000, Peoples R China
[3] Ningxia Med Univ, Ningxia Characterist Tradit Chinese Med Modern Eng, Yinchuan 750000, Peoples R China
[4] Ningxia Med Univ, Coll Basic Med Sci, Yinchuan 750000, Peoples R China
关键词
Ischemic stroke; Traditional Chinese medicines; Natural inhibitors; Ferroptosis; BLOOD-BRAIN-BARRIER; CEREBRAL-ISCHEMIA; IN-VITRO; INJURY; PROTECTS; EXTRACT; RATS;
D O I
10.1016/S1875-5364(24)60603-5
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Ischemic stroke (IS) is a globally prevalent cerebrovascular disorder resulting from cerebral vessel occlusion, leading to significant morbidity and mortality. The intricate pathological mechanisms underlying IS complicate the development of effective therapeutic interventions. Ferroptosis, a form of programmed cell death (PCD) characterized by iron overload and accumulation of lipid peroxidation products, has been increasingly recognized as a key contributor to IS pathology. Traditional Chinese medicines (TCMs) have long been utilized in the management of IS, prompting extensive research into their potential as sources of natural ferroptosis inhibitors. This review investigates the critical role of ferroptosis in IS and provides a comprehensive analysis of current research on natural ferroptosis inhibitors identified in TCMs, aiming to lay a theoretical groundwork for the development of innovative anti-IS therapies.
引用
收藏
页码:746 / 755
页数:10
相关论文
共 50 条
  • [21] Toxicity of traditional Chinese medicines
    Deng, Jou-Fang
    CLINICAL TOXICOLOGY, 2013, 51 (04) : 261 - 262
  • [22] Natural Products Derived from Traditional Chinese Medicine as Novel Inhibitors of the Epidermal Growth Factor Receptor
    Sertel, Serkan
    Plinkert, Peter K.
    Efferth, Thomas
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2010, 13 (10) : 849 - 854
  • [23] Quality Control for Traditional Medicines–Chinese Patent Medicines
    马双成
    World Journal of Integrated Traditional and Western Medicine, 2019, 5 (04) : 28 - 31
  • [24] Research progress of small-molecule natural medicines for the treatment of ischemic stroke
    Kui Liu
    Ling Wang
    Tao Pang
    Chinese Journal of Natural Medicines, 2025, 23 (01) : 21 - 30
  • [25] Evidence of traditional Chinese patent medicine for ischemic stroke: a systematic review
    Wu, B
    Wu, B
    Tan, S
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S64 - S64
  • [26] Meta-analysis of traditional Chinese patent medicine for ischemic stroke
    Wu, Bo
    Liu, Ming
    Liu, Hua
    Li, Wei
    Tan, Song
    Zhang, Shihong
    Fang, Yuan
    STROKE, 2007, 38 (06) : 1973 - 1979
  • [27] Synthesis of Traditional Chinese Medicines-Derived Carbon Dots for Bioimaging and Therapeutics
    He, Jing
    Chen, Jia
    Qiu, Hongdeng
    PROGRESS IN CHEMISTRY, 2023, 35 (05) : 655 - 682
  • [28] Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus
    Li, WL
    Zheng, HC
    Bukuru, J
    De Kimpe, N
    JOURNAL OF ETHNOPHARMACOLOGY, 2004, 92 (01) : 1 - 21
  • [29] Antiviral compounds from traditional Chinese medicines Galla chinese as inhibitors of HCVNS3 protease
    Duan, DL
    Li, ZQ
    Luo, HP
    Zhang, W
    Chen, LR
    Xu, XJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (24) : 6041 - 6044
  • [30] Network pharmacology study of traditional Chinese medicines for stroke treatment and effective constituents screening
    Ren, Liwen
    Zheng, Xiangjin
    Liu, Jinyi
    Li, Wan
    Fu, Weiqi
    Tang, Qin
    Wang, Jinhua
    Du, Guanhua
    JOURNAL OF ETHNOPHARMACOLOGY, 2019, 242